A survey of more than 1,000 people with multiple sclerosis has found extensive use of complementary and alternative medicine – including the use of cannabis. Researchers at Oregon Health & Science University conducted the survey of MS patients in Oregon and Southwest Washington in 2018, with the results published in the journal Multiple Sclerosis and Related Disorders. Around 30% reported they had…
Multiple Sclerosis (MS) is a chronic, sometimes debilitating, autoimmune disease which affects the brain and spinal cord. Symptoms, and the severity of those symptoms, can vary dramatically over time with many sufferers reporting symptoms worsening steadily over time, or going through periods of relapse and remission where symptoms come and go. The disease is most commonly characterized by issues with mobility, ranging…
Multiple Sclerosis is one of those conditions that most of us have heard of, but also seem to know very little about. Often shortened to MS, multiple sclerosis is a degenerative disease that affects movement, senses, and cognitive ability. An increased interest in CBD has led many people to wonder whether CBD oil for MS could prove to be an effective form…
United Greeneries plans to launch online retail sales of medical cannabis in February for Canadians covered by the Access to Cannabis for Medical Purposes Regulations — a program for which certain multiple sclerosis (MS) patients may be eligible. United Greeneries, a unit of Harvest One Cannabis, an umbrella company that also owns Switzerland’s Satipharm, has a medicinal cannabis cultivation and sales license. That allows Harvest One to…
Dutch regulators have signed off on AXIM Biotechnologies’ clinical trial plans for a chewing gum that offers controlled release of cannabinoids to treat multiple sclerosis patients’ pain and spasticity. The Dutch Medicines Evaluation Board’s sign-off on MedChew Rx means AXIM can start trials. A leader in cannabinoid research, New York-based AXIM is developing 16 cannabinoid-based pharmaceutical, nutrition and cosmetic products for conditions that include MS, irritable…
Review of Current Research Regarding the Use of Medicinal Cannabis for MS And MND Symptom Management A report for Multiple Sclerosis New Zealand and Motor Neurone Disease New Zealand December 2017, by Kerry Walker, MSc. Executive Summary With the increasing interest in Medicinal Cannabis for managing pain and spasticity in MS and other chronic conditions Multiple Sclerosis NZ and Motor…
Anqunette Jamison Sarfoh is working to make medical marijuana more widely available. Photo Courtesy of the National Multiple Sclerosis Society After 22 rewarding years on camera, Anqunette Jamison Sarfoh announced in November 2016 that she’d be leaving her morning television news anchor chair at Fox 2 in Detroit, a position she’d held for eight years. She had been on medical…
RICHMOND, Va. — A Virginia mother and teacher, who was diagnosed with multiple sclerosis (M.S.) five years ago, is advocating for a change in Virginia law that would allow people with severe medical conditions to use cannabis oils prescribed by a doctor. Tamra Netzel, who lives in Alexandria, was a teacher for 16 years, and thought she would continue working…
FOR IMMEDIATE RELEASE Medical Cannabis for Multiple Sclerosis Phone: 805.744.2424 Email: info@mc4ms.org MC4MS (Medical Cannabis for Multiple Sclerosis) Names New Executive Director Daron Cooper has joined MC4MS (Medical Cannabis for Multiple Sclerosis) as the new Executive Director. Cooper, will oversee all aspects of the organization which has entered its second year. Coming to MC4MS as a Registered Nurse for 10…